title: Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques.
abstract: Accumulation of tissue iron has been implicated in development of atherosclerotic lesions mainly because of increased iron-catalyzed oxidative injury. However, it remains unknown whether cellular iron import and storage in human atheroma are related to human atheroma development. We found that transferrin receptor 1 (TfR1), a major iron importer, is highly expressed in foamy macrophages and some smooth muscle cells in intimal lesions of human carotid atheroma, mainly in cytoplasmic accumulation patterns. In 52 human carotid atherosclerotic lesions, TfR1 expression was positively correlated with macrophage infiltration, ectopic lysosomal cathepsin L, and ferritin expression. Highly expressed TfR1 and ferritin in CD68-positive macrophages were significantly associated with development and severity of human carotid plaques, smoking, and patient's symptoms. The findings suggest that pathologic macrophage iron metabolism may contribute to vulnerability of human atheroma, established risk factors, and their clinical symptoms. The cytoplasmic overexpression of TfR1 may be the result of lysosomal dysfunction and ectopic accumulation of lysosomal cathepsin L caused by atheroma-relevant lipids in atherogenesis.
authors.affiliation: Division of Experimental Pathology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
authors.forename: Wei
authors.initials: W
authors.lastname: Li
authors.forename: Li-Hua
authors.initials: LH
authors.lastname: Xu
authors.forename: Claes
authors.initials: C
authors.lastname: Forssell
authors.forename: Jerome L
authors.initials: JL
authors.lastname: Sullivan
authors.forename: Xi-Ming
authors.initials: XM
authors.lastname: Yuan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D050197:Atherosclerosis / Q000378:metabolism* / Q000473:pathology; D016893:Carotid Stenosis / Q000378:metabolism* / Q000473:pathology; D056668:Cathepsin L; D002403:Cathepsins / Q000378:metabolism; D003546:Cysteine Endopeptidases / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D007501:Iron / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology; D011990:Receptors, Transferrin / Q000235:genetics / Q000378:metabolism*; D012720:Severity of Illness Index; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D056668:Cathepsin L; D002403:Cathepsins; D003546:Cysteine Endopeptidases; D005293:Ferritins; D007501:Iron; D011990:Receptors, Transferrin; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C534281:CTSL protein, human